CSLB

You are here:

The Cardiology Science Lunch Berlin is sponsored by Servier Deutschland GmbH
and Boehringer Ingelheim Pharma GmbH & Co. KG


History of Speakers

[Englische Übersetzung]

12.04.2017

Prof. Dr. med. Marc Dewey

Cardiac CT: There are More Questions Than Answers?

Department of Radiology, Charité Campus Mitte

05.04.2017

Prof. Dr. Ali El-Armouche

Phosphodiesterasesat the Crossway between cAMPand cGMP Signaling in the Failing Heart

Institute of Pharmacology and Toxicology, TU Dreseden

22.03.2017

Prof. Dr. Matthias Endres

Troponin Elevation in Stroke Patients

Klinik und Hochschulambulanz für Neurologie, Charité Berlin

15.03.2017

Prof. Dr. med. Wolfgang M. Kübler

The Pulmonary Circulation in Left Heart Failure-Vascular Adaptation and Remodeling

Institute of Physiology, Charité – Universitätsmedizin Berlin

22.02.2017

Univ.-Prof. Dr. med. Jeanette Schulz-Menger

Noninvasive Myocardial Tissue Differentiation applying Cardiovascular Magnetic Resonance in Non-Ischemic Heart Disease

Experimental and Clinical Research Center (ECRC), MDC, Berlin

15.02.2017

Prof. Dr. med. Katja Odening

Mechanical Dysfunction in 'Electrical' Disease Long QT Syndrome

Kardiologie und AngiologieI, Universitäts-Herzzentrum Freiburg

08.02.2017

PD Dr. Kristina Kusche-Vihrog

Endothelial Nanomechanics as Indicator for Vascular Function/Dysfunktion

Institute of Physiology II, University of Muenster

01.02.2017

Dr. med. Mathias Wolfrum

Index of Microcirculatory Resistance in the Management of Patients undergoing Primary PCI

Heart Centre, Oxford University Hospitals, Oxford UK

25.01.2017

Prof. Dr. Tim Friede

New Approaches to Cardiovascular Trials and Meta-Analyses

University Medical Center Göttingen

18.01.2017

Prof. Dr. Olaf Oldenburg

What Happens at Night Matters! Sleep-Disordered Breathing in Cardiac Patients

Clinic for Cardiology, Herz- und Diabeteszentrum NRW Ruhr-Universität Bochum, Bad Oeynhausen

11.01.2017

Priv. Doz. Dr. med. Dirk Westermann

Biomarkers in Myocardial Infarction - Novel and Improved Strategies -

Department of General and Interventional Cardiology University Heart Center Hamburg

21.12.2016

Prof. Dr. med. Volkmar Falk

Mechanical Circulatory Assist Therapy for End-Stage Heart Failure

Medical Director and Director of the Dept. of Cardiothoracic and Vascular Surgery at the German Heart Institute Berlin and Charité

14.12.2016

Prof. Dr. Rainer Schulz

Importance of Mitochondrial Proteins for Myocardial Ischemia/Reperfusion Injury and Protection From It

Institute of Physiology, Justus - Liebig University Giessen

30.11.2016

Prof. Dr. rer. nat. Jens Kockskämper

Atrial and Ventricular Remodeling in Hypertensive Heart Disease -New Insights From an Old Model

Institute of Pharmacology and Clinical Pharmacy Philipps-University Marburg

23.11.2016

Prof. Dr. med. Carsten Tschöpe

Development of new treatment strategies in heart failure: targeting inflammation and fibrosis

Charité CVK Dept. of Cardiology and Berlin-Brandenburg Center for Regenerative Therapies (BCRT)

16.11.2016

Priv.-Doz. Dr. med. Christian Opitz

Heart Failure and Pulmonary Hypertension

Klinik für Innere Medizin mit dem Schwerpunkt Kardiologie, DRK Kliniken Berlin Westend

09.11.2016

Prof. Helmut U. Klein

The wearable-cardioverter-defibrillator- a useful tool to improve risk stratification for more beneficial ICD therapy

University of Rochester Medical Center Heart Research Follow up Program

02.11.2016

Jun.-Prof. Dr. med. Philipp Sasse

The Enlightened Heart: Novel Optogenetic Methods to Investigate and Treat Cardiac Arrhythmias.

Institute of Physiology I, University of Bonn

19.10.2016

Priv. Doz. Dr. med. David Leistner

Optical coherence tomography (OCT) - ready for daily use ?

Charité Campus Benjamin Franklin, Dept. of Cardiology

12.10.2016

Prof. Dr. Ursula Müller-Werdan

Impact of inflammatory mediators on cardiac function and cardiac ageing

Charité – Universitätsmedizin Berlin and Protestant Geriatric Centre Berlin (EGZB)

05.10.2016

Prof. Frank Flachskampf

Echocardiographic measures of left ventricular diastolic dysfunction

Department of Clinical Physiology, Uppsala University, Sweden

28.09.2016

Prof. Dr. Salim Seyfried

The Force Within – Biomechanics in Endocardial Development

Institute of Biochemistry and Biology, Potsdam University

21.09.2016

Univ.-Prof. Dr. med. Niels Voigt

Dysfunctional Cellular Calcium Handling in Patients with Atrial Fibrillation

Institute of Pharmacology and Toxicology Georg - August University Göttingen

07.09.2016

Univ.-Prof. Dr. rer. nat. Sabine Steffens

Innate Immunity and Endocannabinoid Signaling in Atherosclerosis and Myocardial Infarction Healing

Institute forCardiovascularPrevention(IPEK) Ludwig-Maximilians-University (LMU) Munich

29.06.2016

PD Dr. Sophie Van Linthout

Lessons from (Cardiac) Stromal Cells

Berlin-Brandenburg Center for Regenerative Therapies, Berlin

22.06.2016

Dr. Justin Davies

Assessment of Coronary Physiology in the Cath Lab

International Centre for Circulatory Health National Heart & Lung Institute, Imperial College, London

15.06.2016

Prof. Dr. Dr. h.c Vera Regitz-Zagrosek

Sex and Gender in Cardiovascular Diseases

Institute for Gender in Medicine Center for Cardiovascular Research, Charité

08.06.2016

Yen - Hung Lin, MD, PhD, FESC

Primary Aldosteronism – The TAIPAI Group From Clinical to Translational Research

Division of Cardiology, Department of Internal Medicine National Taiwan University Hospital, Taipei, Taiwan

01.06.2016

Prof. Rolf Wachter

Baroreceptor Stimulation – Current Role and Future Prospective in Cardiovascular Diseases

Clinic for Cardiology and Pneumology University Medicine Göttingen, Germany

18.05.2016

Dr. Pierpaolo Pellicori, MD, FESC

Identifying (and possibly treating) congestion in patients with chronic heart failure

Academic Cardiology, Castle Hill Hospital, Hull, UK.

04.05.2016

PD Dr. Ralf Dechend

Preeclampsia – Linking Hypertension and Immunology

Experimental and Clinical Research Center, Charité, Campus Buch

27.04.2016

Dr. Marijana Tadic

Hypertensive Heart Disease Seen by the Eyes of Modern Echocardiography

Dept. of Cardiology, University Clinical Hospital Center Belgrade, Serbia

20.04.2016

Ingeborg Friehs, M.D.

Clinical Implications for Mitochondrial Treatment

Department of Cardiac Surgery, Children's Hospital Boston Harvard Medical School, USA

13.04.2016

Prof. Dr. med. Friedrich Luft

A 20-Years Adventure in Mendelian Hypertension

Experimental and Clinical Research Center, MDC Berlin

06.04.2016

Priv.-Doz. Dr. med. Stefan Verlohren

The impact of preeclampsia on maternal cardiovascular health in later life

Department of Obstetrics, Charité-Campus Mitte

23.03.2016

Priv. Doz. Dr. Volker Adams

Heart Failure and the Periphery Impact of exercise training - A molecular point of view

Dept. of Internal Medicine/Cardiology University of Leipzig - Heart Center Leipzig

16.03.2016

Prof. Dr. med. Wolfgang A. Linke

The role of titin in systolic and diastolic cardiac function

Dept. of Cardiovascular Physiology Ruhr University Bochum

09.03.2016

Prof. Dr. med. Duska Dragun

Functional GPCR-recognizing antibodies in cardiovascular medicine

Department of Nephrology and Intensive Care Medicine Charité-Campus Virchow-Klinikum

02.03.2016

Prof. Dr. med. Christoph Maack

Importance of Mitochondrial Proteins for Myocardial Ischemia/Reperfusion Injury and Protection From It

Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg

24.02.2016

Prof. Alan Maisel

Biomarkers to guide therapy of heart failure

Coronary Care Unit and Heart Failure Program, Veterans Affairs San Diego Healthcare System, University of San Diego

17.02.2016

Priv. Doz. Dr. med. Felicitas Escher

Von der Geschichte bis zu neuen Therapieansätzen bei entzündlicher Kardiomyopathie

Klinik für Innere Medizin mit Schwerpunkt Kardiologie, Charité Universitätsmedizin, Campus Virchow-Klinikum

10.02.2016

Prof. Dr. Tobias Schaeffter

New Developments in Cardiovascular and Interventional MRI

Physikalisch-TechnischeBundesanstalt, Medical Physics and Metrological Information Technologies

03.02.2016

Dr. Lorenzo Monserrat , MD, PhD

Next Generation Molecular Diagnosis for Inherited Cardiovascular Diseases

University Hospital A Coruña , Spain, and HealthInCode

28.01.2016

Prof. Vasan Ramachandran, MD, DM, FACC, FAHA

Epidemiology and Risk Assessment in Heart Failure – Novel insights from the Framingham Study

Section of Preventive Medicine and Epidemiology, Boston University School of Medicine, USA

20.01.2016

Prof. Dr. Georg Hansmann

PPARgamma activators for the treatment of cardiopulmonary remodeling and failure

Department of Pediatric Cardiology and Critical Care, Hannover Medical School, Germany

13.01.2016

Prof. Dr. William Louch

Structure-Function Relationships in Cardiac Myocytes: Implications for Development and Disease

Institute for Experimental Medical Research (IEMR) Oslo University Hospital and University of Oslo, Norway

16.12.2015

Pro: PD Dr. med. Heiner Post Contra: PD Dr. med. Frank R. Heinzel, Ph.D.

Large animals are the relevant models for cardiovascular research

Department of Internal Medicine and Cardiology Campus Virchow-Klinikum, Charité Berlin

09.12.2015

Prof. Dr. Mariann Gyöngyösi

Crucial Factor in Translational Research: Large Animal Models of Cardiovascular Diseases

Dept. of Cardiology, Medical University of Vienna, Austria

02.12.2015

Assoc. Prof. Stefano Perlini

Cardiac amyloidoses: pathophysiology, diagnosis and advances in the management

Center for the Study and the Treatment of Systemic Amyloidoses, University of Pavia, Italy

18.11.2015

Prof. Wolfram Döhner

Muscle, Fat and Metabolism in Heart Failure The Whole Body Perspective on Disease and Therapy

Centrum für Schlaganfallforschung Berlin - Charité

04.11.2015

Prof. Gernot Plank

Computing the Heart Beat : The Role of Computer Models in Basic Research and Clinical Applications

Institute of Biophysics, Medical University of Graz, Austria

28.10.2015

Prof. Clemens Schmitt

Essential role for premature senescence of myofibroblasts in myocardial fibrosis

Charité, Hematology / Oncology

21.10.2015

Dipl. Wirt.-Ing. Paul Burggraf

Devoloping Smart Health Monitoring

Fraunhofer-Institut für Graphische Datenverarbeitung IGD - IDE

14.10.2015

Prof. Michael Gotthardt

Splicing, Sarcomeres And Systole A Molecular Approach to Cardiac Function and Disease

Max - Delbrück - Center for Molecular Medicine (MDC), Berlin

07.10.2015

Prof. Andreas Götte

Upstream Therapy of Atrial Fibrillation - New Perspectives ?

St Vincenz Hospital Paderborn and University of Magdeburg

30.09.2015

Prof. SaskoKedev, MD., PhD.

Total wrist access (radial and ulnar) for primary PCI

University St. Cyril & Methodius in Skopje, Macedonia

23.09.2015

Prof. Norbert Hübner

Translational Regulation of the Cardiac Phenotype

Max-Delbrück-Center for Molecular Medicine (MDC), Berlin

16.09.2015

Prof. Dr. Dr. med. Thomas Thum

Small and Long Noncoding RNAs in Cardiac Remodelling – Focus on Translation

Department of Molecular Cardiology, University of Düsseldorf

09.09.2015

Prof. Ulrich Flögel

MR Imaging of Myocardial Metabolism

Department of Molecular Cardiology, University of Düsseldorf

26.08.2015

PD Dr. Gábor G. Tóth

Paradigm shift in coronary revascularization strategies: function over anatomy in the catheterization laboratory

Medical University of Graz, Austria

19.08.2015

PD Dr. Dirk Strunk

Regenerative Potential and Clinical Applicability of Stem Cells (EPC & MPC)

Paracelsus Medical University, Salzburg

12.08.2015

Dr. Mareike Lankeit

Risk stratification of pulmonary embolism – biomarkers, clinical scores and therapeutic consequences

Universitätsmedizin Maiz

05.08.2015

PD Dr. Dr. Stephan von Haehling

The Muscle in Dire Straits: Wasting in Heart Failure

Herzzentrum Göttingen

29.07.2015

Dr. Jakob Völkl

Aldosterone in Vascular Calcification

University of Tübingen

22.07.2015

Prof. Friedrich Köhler

Telemedicine - an update 2015

Charité - Zentrum für kardiovaskuläre Telemedizin

15.07.2015

Prof. Pieter de Tombe

Sarcomere dynamics in health and disease

Loyola University Chicago

08.07.2015

Prof. Ulrich Kintscher

Lipidomics - the new "omics" in cardiovascular medicine

Charité - Institut für Pharmakologie

01.07.2015

Prof. Jonathan Kimmelman

Why drug development must fail to succeed

McGill University , Montreal, CA